[What do we know about Kawasaki disease and COVID-19?] / ¿Qué sabemos de la enfermedad de Kawasaki y COVID 19?
Andes Pediatr
; 92(2): 281-287, 2021 Apr.
Article
in Spanish
| MEDLINE | ID: covidwho-1248567
ABSTRACT
In addition to the existing concern generated during the current COVID-19 pandemic outbreak in the adult population, we see how this pathology affects the pediatric population in the same way. Several countries have declared health alerts for a new syndrome that occurs late in children exposed to COVID-19, called "multisystem inflammatory syndrome". These patients manifest symptoms si milar to Kawasaki disease, but at rare ages, and it is considered as the cytokine storm manifestation in children. The objective of this review is to present the available information on COVID-19 and its re lationship with Kawasaki's disease, as well as to explain the current hypothesis of this new syndrome, its physiopathology, clinical presentation, key differences with Kawasaki's disease, and its possible therapeutic interventions.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Systemic Inflammatory Response Syndrome
/
COVID-19
/
Mucocutaneous Lymph Node Syndrome
Type of study:
Diagnostic study
/
Prognostic study
Topics:
Long Covid
Limits:
Child
/
Humans
Language:
Spanish
Journal:
Andes Pediatr
Year:
2021
Document Type:
Article
Affiliation country:
Andespediatr.v92i2.2786
Similar
MEDLINE
...
LILACS
LIS